SUPERNUS PHARMACEUTICALS, INC.

By person

17 insiders · 165 transactions

159×

Jack A. Khattar holds 159 times base salary in stock. $165.52M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack A. Khattar last reported holding, valued at $50.48, the price Common Stock was last bought or sold at on the open market here, on 18 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Khattar Jack A.

President, CEO

$189.98K (1)

$39.33M (41) scheduled

−$39.14M

3,278,901

5.64%

$165.52M

+28.0%

Bhatt Padmanabh P.

Sr. VP of IP, CSO

—

$19.25M (44) scheduled

−$19.25M

18,637

0.0321%

$940.80K

−69.8%

PATRICK GREGORY S

Sr. VP Chief Financial Officer

—

$10.38M (12) scheduled

−$10.38M

44,463

0.0765%

$2.24M

—

Schwabe Stefan K.F.

Executive Vice President & CMO

—

$9.89M (5) scheduled

−$9.89M

2,772

0.0048%

$139.93K

0.0%

Vaughn Victor

Sr. VP of Sales & Marketing

—

$7.79M (10) scheduled

−$7.79M

9,344

0.0161%

$471.69K

0.0%

Mottola Frank

SVP, Chief Tech. Ops. Officer

—

$2.71M (8) scheduled

−$2.71M

19,544

0.0336%

$986.58K

+99.7%

GEMAYEL GEORGES

Director

—

$2.35M (6) scheduled

−$2.35M

27,277

0.0469%

$1.38M

—

NEWHALL CHARLES W III

Director

—

$2.00M (7) scheduled

−$2.00M

124,119

0.2135%

$6.27M

+37.8%

Hudson Frederick M.

Director

—

$1.18M (6)

−$1.18M

60,413

0.1039%

$3.05M

+1,108%

Martin Tami Tillotson

Sr. V.P., Regulatory Affairs

—

$1.18M (7) scheduled

−$1.18M

86,933

0.1496%

$4.39M

−1.8%

DEC TIMOTHY C

Senior Vice-President & CFO

—

$524.09K (1)

−$524.09K

9,129

0.0157%

$460.83K

+176.5%

Horich William Todd

SVP, Commercial Operations

—

$483.80K (2)

−$483.80K

0.0000%

$0.00

−100.0%

Sensenig Bethany

Director

—

$455.11K (3) scheduled

−$455.11K

0.0000%

$0.00

—

Rubin Jonathan

SVP, Chief Medical Officer

—

$36.29K (1) scheduled

−$36.29K

13,979

0.0240%

$705.66K

+465.7%

SIEBERT JOHN M

Director

—

87,943

0.1513%

$4.44M

+349.5%

Barlow Carrolee

Director

—

27,045

0.0465%

$1.37M

—

Nuerge William A.

Director

—

23,750

0.0409%

$1.20M

0.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Khattar Jack A.

13 Mar 2026

President, CEO

Sold on a plan indirect

120

$51.75

$6.21K

Khattar Jack A.

13 Mar 2026

President, CEO

Sold on a plan indirect

10,742

$51.00

$547.84K

Khattar Jack A.

13 Mar 2026

President, CEO

Sold on a plan indirect

24,138

$50.09

$1.21M

NEWHALL CHARLES W III

9 Oct 2025

Director

Sold on a plan

1,200

$51.55

$61.86K

NEWHALL CHARLES W III

9 Oct 2025

Director

Sold on a plan

23,800

$50.73

$1.21M

NEWHALL CHARLES W III

27 Aug 2025

Director

Sold on a plan

3,588

$45.01

$161.50K

NEWHALL CHARLES W III

25 Aug 2025

Director

Sold on a plan

1,000

$45.00

$45.00K

NEWHALL CHARLES W III

22 Aug 2025

Director

Sold on a plan

1,412

$45.00

$63.54K

Sensenig Bethany

14 Aug 2025

Director

Sold on a plan

5,369

$42.25

$226.84K

Show all 165 transactions →

SUPERNUS PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out